Market Overview

Morning Market Losers

Share:
Related RPRX
Repros Submits New Drug Application to FDA for Androxal
Morning Market Movers
FDA imposes limits on testosterone drugs and labeling changes to warn of potential heart risks (Seeking Alpha)
Related JOSB
#PreMarket Primer: Monday, June 9: Tyson Foods Wins Bidding War For Hillshire
Benzinga's Weekend M&A Chatter

Repros Therapeutics (NASDAQ: RPRX) shares dipped 18.27% to $15.21 at 9:50 am. Repros provided a revised date for expected clinical results from the first pivotal study of Androxal.

TORM A/S (NASDAQ: TRMD) fell 18.05% to $3.27. TORM's trailing-twelve-month ROE is -91.52%.

Jos. A Bank Clothiers (NASDAQ: JOSB) shares lost 15.69% to $39.01. Jos. A Bank Clothiers projects its FY12 net income to be around 20% lower than the prior year.

Chanticleer Holdings (NASDAQ: HOTR) dropped 11.10% to $2.4001. Chanticleer shares have dropped 55.00% over the past 52 weeks, while the S&P 500 index has gained 14.47% in the same period.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (JOSB + HOTR)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→